WEB REGISTRATION CLOSES:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center Mahender Gurram, Ph.D.Senior Director, DS Development, Mfg, & CMC at Entrada TherapeuticsSpeaker
Profile
Trained synthetic organic chemist with >15 years of experience in synthesis of drug substances, intermediates in CROs and in innovative Biotechs. Significant experience in clinical and late phase product development and CMC. Currently overseeing development and manufacturing of PMOs and related drug substances at Entrada therapeutics.
Agenda Sessions
Strategies for Oligonucleotides Purification Applicable for Clinical Products Manufacture
, 11:45amView Session